From Zacks Investment Research: 2025-05-13 17:54:00

President Trump signed an Executive Order to combat “Big Pharma price gouging,” aiming to reduce prescription drug prices by 80-90%. Despite this, Eli Lilly (LLY) saw a 2.86% increase in stock value on Monday, reaching $755.57. Technical analyst Dave Bartosiak examined LLY’s moving averages, support/resistance levels, chart patterns, and volume analysis to provide insights for investors. While technical analysis is valuable, other factors like fundamental analysis and market sentiment should also be considered when making investment decisions.



Read more at Zacks Investment Research: Trump’s EO Targets Big Pharma Stocks like Eli Lilly – May 13, 2025